.Pharmacolibrary.Drugs.ATC.J.J01DD14 .Pharmacolibrary.Drugs.ATC.J.J01DD14| name: | Ceftibuten |
| ATC code: | J01DD14 | route: | oral |
| n-compartments | 1 |
Ceftibuten is a third-generation oral cephalosporin antibiotic used primarily for the treatment of infections caused by susceptible strains of bacteria, such as acute bacterial exacerbations of chronic bronchitis, pharyngitis, tonsillitis, and urinary tract infections. It is currently approved for use in several countries and is valued for its once-daily dosing and oral administration route.
Pharmacokinetic parameters in healthy adult volunteers after single oral dose administration.
Guay, DR (2000). Pharmacodynamics and pharmacokinetics of cefdinir, an oral extended spectrum cephalosporin. The Pediatric infectious disease journal 19(12 Suppl) S141–S146. DOI:10.1097/00006454-200012001-00002 PUBMED:https://pubmed.ncbi.nlm.nih.gov/11144395
Langtry, HD, & Balfour, JA (1998). Azithromycin. A review of its use in paediatric infectious diseases. Drugs 56(2) 273–297. DOI:10.2165/00003495-199856020-00014 PUBMED:https://pubmed.ncbi.nlm.nih.gov/9711451
Pichichero, ME, et al., & Nicolau, DP (2008). Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children. Paediatric drugs 10(6) 391–397. DOI:10.2165/0148581-200810060-00006 PUBMED:https://pubmed.ncbi.nlm.nih.gov/18998749